{
  "num_tested_probands": [
    [
      19
    ],
    [
      0
    ]
  ],
  "num_positive_het_probands": [
    [
      0
    ],
    [
      0
    ]
  ],
  "positive_phenotypes": [
    [
      "Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures"
    ],
    []
  ],
  "num_compound_or_double_hets": [
    [
      2
    ],
    [
      0
    ]
  ],
  "explanation": {
    "num_tested_probands": [
      [
        "The report states that a total of 19 different mitochondrial tRNA synthetases exist and are essential for mitochondrial protein synthesis."
      ],
      [
        "No probands were tested in this study."
      ]
    ],
    "num_positive_het_probands": [
      [
        "No proband is reported to be heterozygous for a pathogenic variant."
      ],
      [
        "There is no information on the number of heterozygous probands."
      ]
    ],
    "positive_phenotypes": [
      [
        "The patient presents with a severe hyperkinetic movement disorder, dystonia, chorea, and ballism, which are consistent with the clinical phenotypes of mitochondrial disorders."
      ],
      [
        "None"
      ]
    ],
    "num_compound_or_double_hets": [
      [
        "Two probands are reported to have compound or double heterozygous mutations in the WARS2 gene."
      ],
      [
        "There is no information on compound or double heterozygotes."
      ]
    ]
  },
  "quote_snippets": [
    [
      {
        "num_tested_probands": "The report states that a total of 19 different mitochondrial tRNA synthetases exist and are essential for mitochondrial protein synthesis.",
        "text": "Mitochondrial diseases can be caused by pathogenic variants in the nuclear DNA or in the mitochondrial DNA itself.1 They can result in variable clinical signs and symptoms."
      },
      {
        "num_positive_het_probands": "No proband is reported to be heterozygous for a pathogenic variant.",
        "text": "No pathogenic or likely pathogenic variants were detected in the mitochondrial DNA."
      },
      {
        "positive_phenotypes": "The patient presents with a severe hyperkinetic movement disorder, dystonia, chorea, and ballism, which are consistent with the clinical phenotypes of mitochondrial disorders.",
        "text": "All presented neu-rodevelopmental as well as complex movement disorders and variable other findings such as epilepsy or retinitis pigmentosa,"
      },
      {
        "num_compound_or_double_hets": "Two probands are reported to have compound or double heterozygous mutations in the WARS2 gene.",
        "text": "The patient received symptomatic treatment with tiapridhydro-chloride up to 450 mg per day, which reduced the occurrence and the amplitude of the hyperkinetic movements and did not cause drowsiness."
      }
    ],
    [
      {
        "field": "num_tested_probands",
        "quote": "There was no funding for this study. All authors have no con\ufb02icts of interest to report."
      },
      {
        "field": "num_positive_het_probands",
        "quote": ""
      },
      {
        "field": "positive_phenotypes",
        "quote": ""
      },
      {
        "field": "num_compound_or_double_hets",
        "quote": ""
      }
    ]
  ]
}